Jim Cramer outlines the vast differences in strategy when it comes to dealing with politics and the stock market. » Read More
Alkermes said its lead depression drug met the main goal of a late-stage trial, sending its shares up 48 percent in extended trading.
FANG stocks are up more than 6 percent in October, compared to a 2 percent loss by an equal-weight basket of tech stocks
All the chips are falling in place for a Qualcomm and NXP Semiconductors deal to be finalized as early as next week, according to Bloomberg.
Shares of Deutsche Bank briefly recovered levels from before the news of the Department of Justice's demand for a $14 billion settlement.
Senior executives from both companies have begun chats over business strategies, according to Bloomberg.
Rich Pzena made his comments on Thursday in an interview with CNBC's Scott Wapner on "Halftime Report."
Rite Aid stock jumped 6 percent Thursday afternoon, following a mutual decision with Walgreens to delay their merger agreement until January.
Earnings from GE and Honeywell could perpetuate another weak earnings season for industrials or signal the start of a much needed reversal.
UBS says iPhone 7 interest in China is "tepid."
Now that earnings season is here, are third-quarter revenue estimates too high?
Snap-On shares jumped nearly 7 percent on Thursday after the company reported better-than-expected earnings.
Shares of Landstar climbed more than 9 percent in early trading on Tuesday after releasing an earnings report that topped analysts' estimates.
Guggenheim upgrades its rating on Morgan Stanley to buy from neutral.
Shares of American Express rose 9 percent Thursday after the company posted an earnings beat and raised its guidance.
Three well-known technologists weighed in on how they would approach a turnaround at Twitter, as the future of the company remains unclear.
Shares of Cree fell 11 percent Wednesday following the company's underwhelming quarterly fiscal report.
Get the best of CNBC in your inbox